InnovaRx Innova Health Strategies

E74.818

Other disorders of glucose transport

Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 11 never code together
E74code
Excludes1
  • diabetes mellitus (E08-E13)E08-E13
  • hypoglycemia NOS (E16.2)E16.2
  • increased secretion of glucagon (E16.3)E16.3
  • mucopolysaccharidosis (E76.0-E76.3)E76.0-E76.3
E70-E88block
Excludes1
  • androgen insensitivity syndrome (E34.5-)E34.5-
  • congenital adrenal hyperplasia (E25.0)E25.0
  • hemolytic anemias attributable to enzyme disorders (D55.-)D55.-
  • Marfan syndrome (Q87.4-)Q87.4-
  • 5-alpha-reductase deficiency (E29.1)E29.1
Excludes2
  • Ehlers-Danlos syndromes (Q79.6-)Q79.6-
E00-E89chapter
Excludes1
  • transitory endocrine and metabolic disorders specific to newborn (P70-P74)P70-P74

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes 2
Inclusion terms
  • (Familial) renal glycosuria
E00-E89chapter
Notes
  • All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.E05.8E07.0E16-E31E34.-
Index entries leading here 3
  • Deficiency, deficient
  • Disorder (of) — see also Disease
  • Glycosuria R81
Alongside this code 2 same parent — E74.81
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

CMS22HCC23 ESRD21HCC23 ESRD24HCC23 RX08HCC43

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
E74.81
Block
E70-E88
Siblings
2

Present FY2024–FY2027.